What bupropion formulation and dosing schedule should be used for a 74-year-old patient starting at 100 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bupropion 100 mg: Formulation and Dosing for a 74-Year-Old Patient

For a 74-year-old patient starting bupropion at 100 mg, this is a non-standard dose that requires clarification of the clinical indication, as standard formulations do not include 100 mg tablets for the extended-release preparations commonly used today.

Standard Formulations and Dosing

The FDA-approved bupropion formulations are 1:

  • Bupropion Immediate Release (IR): Dosed 3 times daily
  • Bupropion Sustained Release (SR): Dosed twice daily
  • Bupropion Extended Release (XL): Dosed once daily (most commonly prescribed)

The bupropion XL formulation comes in 150 mg and 300 mg tablets only 1. A 100 mg dose would only be available in the older immediate-release formulation, which requires three-times-daily dosing.

Clinical Context Matters

For Depression Treatment:

If treating depression in this elderly patient, start with bupropion XL 150 mg once daily rather than attempting to use a 100 mg dose 1, 2. The XL formulation is bioequivalent to other formulations but offers superior adherence with once-daily dosing 3.

In elderly patients with depression:

  • Mean effective doses ranged from 150-400 mg daily in naturalistic studies 4
  • 74% response rates were achieved at mean doses of 240 mg daily 4
  • Start at 150 mg XL once daily and titrate based on response and tolerability

For Smoking Cessation:

If this is for smoking cessation, the NCCN guidelines specify 5:

  • Days 1-3: 150 mg orally once daily
  • Day 4 onward: 150 mg orally twice daily (if tolerated)
  • Maximum 300 mg per day
  • Initiate 1-2 weeks prior to quit date

Critical Safety Considerations in a 74-Year-Old

Screen carefully for contraindications before prescribing 5:

  • Seizure risk factors: History of stroke, brain metastases, or other conditions lowering seizure threshold (absolute contraindication)
  • Drug interactions: MAO inhibitors (contraindicated), tamoxifen (contraindicated), CYP2B6 inhibitors like clopidogrel or ticlopidine (increase bupropion levels by 40-85%) 1
  • Closed-angle glaucoma: Contraindicated 5
  • Renal impairment: Common in elderly; requires dose reduction and less frequent dosing 1
  • Hepatic impairment: In severe cirrhosis, bupropion levels increase 3-fold with 70% higher Cmax 1

Practical Recommendation

If the patient has been prescribed "100 mg bupropion," clarify with the prescriber whether this represents:

  1. A dosing error - Should likely be 150 mg XL once daily
  2. Bupropion IR 100 mg three times daily (300 mg total daily dose) - an older regimen rarely used today
  3. An attempt at dose reduction for tolerability - in which case, consider starting 150 mg XL every other day initially, then advancing to daily dosing

For most elderly patients, the optimal starting approach is bupropion XL 150 mg once daily taken in the morning 1, 2. This can be increased to 300 mg once daily after 4-7 days if tolerated and clinically indicated. The once-daily XL formulation improves adherence and has equivalent efficacy to multiple-daily-dosing formulations 2, 3.

Monitoring Requirements

  • Neuropsychiatric symptoms: Monitor for depression worsening, suicidal ideation, hostility (though risk is not significantly elevated versus placebo) 5
  • Blood pressure: Can increase slightly
  • Weight: Expect 0.5-1.0 kg weight loss 6
  • Metabolite accumulation: Elderly patients are at increased risk for accumulation of active metabolites with half-lives of 20-37 hours 1

The extended-release shell may appear intact in stool - this is normal and does not indicate malabsorption 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.